Triple

T4850373
Position Surface form Disambiguated ID Type / Status
Subject Pfizer E108398 entity
Predicate hasSubsidiary P254 FINISHED
Object G.D. Searle
G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
E476631 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: G.D. Searle | Statement: [Pfizer, hasSubsidiary, G.D. Searle]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: G.D. Searle
Context triple: [Pfizer, hasSubsidiary, G.D. Searle]
  • A. George Merck
    George Merck was an American pharmaceutical executive best known for leading and expanding Merck & Co. into a major global drug company in the early 20th century.
  • B. Fritz Hoffmann-La Roche
    Fritz Hoffmann-La Roche was a Swiss entrepreneur and industrialist who founded the global healthcare and pharmaceutical company Roche in the late 19th century.
  • C. Charles Pfizer
    Charles Pfizer was a German-American chemist and entrepreneur who co-founded the pharmaceutical company Pfizer in the 19th century.
  • D. B. B. Collip
    B. B. Collip was a Canadian biochemist best known as a key member of the team that developed insulin as a treatment for diabetes.
  • E. Henry Wellcome
    Henry Wellcome was a British-American pharmaceutical entrepreneur and philanthropist whose fortune and vision led to the creation of one of the world’s largest biomedical research charities.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: G.D. Searle
Triple: [Pfizer, hasSubsidiary, G.D. Searle]
Generated description
G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: G.D. Searle
Target entity description: G.D. Searle is a pharmaceutical company best known for developing the artificial sweetener aspartame and for its role in pioneering modern drug research before becoming part of larger industry conglomerates.
  • A. George Merck
    George Merck was an American pharmaceutical executive best known for leading and expanding Merck & Co. into a major global drug company in the early 20th century.
  • B. Fritz Hoffmann-La Roche
    Fritz Hoffmann-La Roche was a Swiss entrepreneur and industrialist who founded the global healthcare and pharmaceutical company Roche in the late 19th century.
  • C. Charles Pfizer
    Charles Pfizer was a German-American chemist and entrepreneur who co-founded the pharmaceutical company Pfizer in the 19th century.
  • D. B. B. Collip
    B. B. Collip was a Canadian biochemist best known as a key member of the team that developed insulin as a treatment for diabetes.
  • E. Henry Wellcome
    Henry Wellcome was a British-American pharmaceutical entrepreneur and philanthropist whose fortune and vision led to the creation of one of the world’s largest biomedical research charities.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd440a89548190a5f14ba6da6b97dc completed March 20, 2026, 12:56 p.m.
NER Named-entity recognition batch_69bd6d1e5cf08190bd6b6a524748f170 completed March 20, 2026, 3:51 p.m.
NED1 Entity disambiguation (via context triple) batch_69be67da14d48190a994a11eb7a674b5 completed March 21, 2026, 9:41 a.m.
NEDg Description generation batch_69be6864608c8190af22cc3ed949e1b9 completed March 21, 2026, 9:44 a.m.
NED2 Entity disambiguation (via description) batch_69be68e5b4e88190b7cd53d495f18a0f completed March 21, 2026, 9:46 a.m.
Created at: March 20, 2026, 1:25 p.m.